Jeffrey Thatcher
Chief Tech/Sci/R&D Officer at SPECTRAL AI, INC.
Net worth: - $ as of 30/04/2024
Profile
Jeffrey Thatcher is currently working as the Chief Scientist at Spectral AI, Inc. Prior to this, he worked as the Chief Scientist at Spectral MD Holdings Ltd.
He completed his undergraduate degree at Texas Tech University and his doctorate at The University of Texas Southwestern Medical Center.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
02/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Jeffrey Thatcher active positions
Companies | Position | Start |
---|---|---|
SPECTRAL AI, INC. | Chief Tech/Sci/R&D Officer | 11/09/2023 |
Former positions of Jeffrey Thatcher
Companies | Position | End |
---|---|---|
Spectral MD Holdings Ltd.
Spectral MD Holdings Ltd. Packaged SoftwareTechnology Services Spectral MD Holdings Ltd. develops proprietary artificial intelligence algorithms and optical technology to help clinicians to make faster treatment decisions in wound care sector. Its DeepView Wound Imaging solution is an internally developed AI and multispectral imaging technology that enables the user to distinguish between damaged and healthy human tissue. The company was founded in 2009 and is headquartered in Dallas, TX. | Chief Tech/Sci/R&D Officer | - |
Training of Jeffrey Thatcher
Texas Tech University | Undergraduate Degree |
The University of Texas Southwestern Medical Center | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SPECTRAL AI, INC. | Health Technology |
Private companies | 1 |
---|---|
Spectral MD Holdings Ltd.
Spectral MD Holdings Ltd. Packaged SoftwareTechnology Services Spectral MD Holdings Ltd. develops proprietary artificial intelligence algorithms and optical technology to help clinicians to make faster treatment decisions in wound care sector. Its DeepView Wound Imaging solution is an internally developed AI and multispectral imaging technology that enables the user to distinguish between damaged and healthy human tissue. The company was founded in 2009 and is headquartered in Dallas, TX. | Technology Services |
- Stock Market
- Insiders
- Jeffrey Thatcher